Answers are grounded in this paper and cite their sources.
Background: Interferon (IFN) are small proteins that belong to the cytokine family and may interfere with viral infections and some cancers. There are many studies focused on the PEGylated interferon's bioactivity. In this study, we used solid lipid nanoparticles (SLNs) to produce new drug formulations, with the aim of reducing costs, increasing effectiveness, and also reducing side effects, and the biological effects of the formulation and comparing the obtained results with the interferon alpha-2b and PEGylated interferon alpha-2b.
No takes yet. Share an insight, caveat, or question.
Doroud et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: